TABLE 1.
Baseline characteristics of the 93 kidney transplant recipients.
| Characteristics | N (%) or mean ± SD |
|---|---|
| Female sex | 38 (40.9) |
| Age (years) | 44 ± 11 |
| Comorbidities | |
| Hypertension | 76 (81.7) |
| Diabetes mellitus | 11 (11.8) |
| Hyperparathyroidism | 29 (31.2) |
| HBV infection | 4 (4.3) |
| Unknown | 1 (1.1) |
| Transplant type | |
| DDKT | 68 (73.1) |
| LRKT | 25 (26.9) |
| BMI (kg/m2) | 22.6 ± 3.7 |
| CMV serostatus | |
| D+/R+ | 88 (94.6) |
| D−/R+ | 2 (2.2) |
| D+/R− | 1 (1) |
| D−/R− | 0 |
| Unknown donor CMV status/R+ | 2 (2.2) |
| Re-transplantation | 7 (7.5) |
| HLA mismatch | |
| 0 | 10 (10.8) |
| 1–3 | 72 (77.4) |
| 4–6 | 11 (11.8) |
| PRA (%) | |
| 0–10 | 71 (76.3) |
| 11–50 | 10 (10.8) |
| >50 | 12 (12.9) |
| Induction therapy | |
| Basiliximab | 66 (70.9) |
| Anti-thymocyte globulin | 22 (23.7) |
| None | 5 (5.4) |
| Maintenance therapy | |
| Tacrolimus | 86 (92.5) |
| Cyclosporine | 7 (7.5) |
| Mycophenolate sodium | 21 (22.6) |
| Mycophenolate mofetil | 72 (77.4) |
| Prednisolone | 93 (100) |
Abbreviations: SD, standard deviation; HBV, hepatitis B virus; DDKT, deceased-donor kidney transplantation; LRKT, living-related kidney transplantation; BMI, body mass index; CMV, cytomegalovirus; D, donor; R, recipient; +, seropositive; −, seronegative; HLA, human leukocyte antigen; PRA, panel-reactive antibody.